Tuesday Morning Corporation (NASDAQ:TUES) shares increased 5.89% in last trading session and ended the day at $6.83. TUES Gross Margin is 36.10% and its has a return on assets of 1.20%. Tuesday Morning Corporation (NASDAQ:TUES) quarterly performance is -10.25%.
Tuesday Morning Corporation (NASDAQ:TUES) announced the appointment of Steven R. Becker as CEO, effective immediately. Burman brings specialty retail experience to the chairmanship, including serving as CEO of Signet Jewelers and more recently chairman of the board of Zale Corporation.
Eros International Plc (NYSE:EROS) ended the last trading day at $9.87. Company weekly volatility is calculated as 10.70% and price to cash ratio as 3.77. Eros International Plc (NYSE:EROS) showed a weekly performance of 6.13%.
On 5 December, Eros International Plc (NYSE:EROS) said that, it once again partners with Padma Shri awardee Sanjay Leela Bhansali. Besides presenting Bajirao Mastani, the filmmaker’s most ambitious work of art, it also promises to transport audiences to the land of war, passion, love and grandeur.
On 16 December, Bio-Path Holdings, Inc. (NASDAQ:BPTH) shares moved down -5.70% and was closed at $1.49. Bio-Path Holdings, Inc. (NASDAQ:BPTH) year to date (YTD) performance is -43.98%.
Bio-Path Holdings, Inc. (NASDAQ:BPTH) announced that data from the Phase I and safety segment of the Phase II clinical trials of its lead product candidate BP-100-1.01 (or BP1001, Liposomal Grb2 antisense) in the treatment of blood cancers were presented yesterday by Dr. Jorge Cortes, Deputy Chair of the Department of Leukemia at The University of Texas MD Anderson Cancer Center and Chair of Bio-Path’s Scientific Advisory Board, during a poster session at the 57th American Society of Hematology (ASH) Annual Meeting in Orlando, Florida.
Albemarle Corporation (NYSE:ALB) shares increased 6.47% in last trading session and ended the day at $51.83. ALB Gross Margin is 31.10% and its has a return on assets of 1.70%. Albemarle Corporation (NYSE:ALB) quarterly performance is 15.73%.
Albemarle Corporation (NYSE:ALB) announced that it has signed a definitive agreement to sell its Mineral Flame Retardants and Specialty Chemicals businesses to Huber Engineered Materials, a division of J.M. Huber Corporation, a leading global manufacturer of flame retardant additives. The transaction includes Albemarle’s Martinswerk GmbH subsidiary and manufacturing facility located in Bergheim, Germany and Albemarle’s 50% ownership interest in MAGNIFIN Magnesiaprodukte GmbH, a joint-venture with RHI AG at Breitenau, Austria.
Seres Therapeutics, Inc. (NASDAQ:MCRB) caters to the Healthcare space. Its weekly performance is 19.65%. On the last day of trading company shares ended up at $43.85. Seres Therapeutics, Inc. (NASDAQ:MCRB) distance from 50-day simple moving average (SMA50) is -5.24%.
Zacks Investment Research downgraded shares of Seres Therapeutics, Inc. (NASDAQ:MCRB) from a hold rating to a sell rating in a report released on Tuesday, MarketBeat reports.
Leave a Reply